Fertility Services Market Trends, Industry Analysis, Key Players, and Forecast 2024-2032

Comments · 1 Views

The global fertility services market size reached US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032.

IMARC Group’s latest report, titled “Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the fertility services market trends. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global fertility services market size reached US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 129.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032.

Fertility Services Market Overview:

Fertility services encompass medical procedures that assist individuals and couples in conceiving. These services include a range of treatments like in vitro fertilization (IVF), intrauterine insemination (IUI), and fertility medications. The working mechanism of these services often involves enhancing reproductive capabilities or addressing fertility issues. Characteristics of fertility services include personalized treatment plans, use of advanced reproductive technologies, and a focus on patient care and support. The properties of these services are marked by their technical sophistication and evidence-based approach. Advantages of fertility services include improved chances of conception, options for individuals with various fertility challenges, and advancements in reproductive genetics and embryology.

Get Sample Copy of Report at – https://www.imarcgroup.com/fertility-services-market/requestsample

Fertility Services Market Trends:

The global market is majorly driven by the increasing prevalence of infertility issues among couples worldwide. Concurrently, the growing acceptance and awareness of fertility treatments are significantly contributing to the market's growth. Furthermore, the rise in the average age of first-time parenthood, leading to age-related fertility issues, is acting as an important growth-inducing factor. Enhanced success rates of fertility treatments due to technological advancements also play a pivotal role in market expansion. Additionally, the evolving societal acceptance of assisted reproductive techniques is fostering market growth. The market benefits from the increasing accessibility and affordability of fertility services, making them available to a broader demographic. Government initiatives and insurance coverage for fertility treatments are further propelling the market. Moreover, the expansion of fertility clinics with state-of-the-art facilities is creating opportunities in the market. Other factors aiding the market include increased investment in research and development, the growing trend of delayed family planning, and the rising preference for personalized fertility solutions.

Competitive Landscape with Key Players:

  • Instituto Bernabéu Group
  • INVO Bioscience, Inc.
  • Monash IVF Group
  • Apollo Hospitals Enterprise Ltd.
  • CARE Fertility Group Ltd.
  • Carolinas Fertility Institute
  • Genea Limited
  • The Cooper Companies, Inc.
  • Virtus Health Group
  • Vitrolife Sweden AB
  • The Johns Hopkins Health System Corporation
  • Medicover AB (publ)
  • OvaScience, Inc.
  • Progyny, Inc.
  • Xytex Corporation.

Key Market Segmentation:

Breakup by Cause of Infertility:

  • Male Infertility
  • Female Infertility

Breakup by Procedure:

  • In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • Surrogacy
  • In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • Intrauterine Insemination (IUI)
  • Others

Breakup by Service:

  • Fresh Non-Donor
  • Frozen Non-Donor
  • Egg and Embryo Banking
  • Fresh Donor
  • Frozen Donor

Breakup by End-User:

  • Fertility Clinics
  • Hospitals
  • Surgical Centres
  • Clinical Research Institutes
  • Cryobanks

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

Comments